Top compounds associated with response to PBX4


Feature Type Standardized
Nominal ANOVA
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.077 0.01
mRNA GSK525762A CTRPv2 pan-cancer AAC -0.072 0.02
mRNA RDEA119 GDSC1000 pan-cancer AAC -0.072 0.02
mRNA ruxolitinib GDSC1000 pan-cancer AAC -0.078 0.02
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.085 0.02
mRNA GSK269962A GDSC1000 pan-cancer AAC -0.074 0.02
mRNA Lisitinib GDSC1000 pan-cancer AAC -0.078 0.02
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.08 0.02
mRNA ML239 CTRPv2 pan-cancer AAC 0.081 0.02
mRNA tubastatin A GDSC1000 pan-cancer AAC -0.069 0.02
Download CSV